Ethnic differences in the frequency of subtypes of childhood acute lymphoblastic leukemia: Results of the Malaysia-Singapore Leukemia Study Group

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 1, 2007, Pages 27-31

  Ariffin, Hany ^a   Chen, Siew Peng ^b   Kwok, Cecilia S ^b   Quah, Thuan Chong ^b   Lin, Hai Peng ^c   Yeoh, Allen E J ^b,c  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^b SUBANG JAYA MEDICAL CENTRE   (Malaysia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Childhood leukemia; Cytogenetics; Fusion transcripts

Indexed keywords

BCR ABL PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR PBX1; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ASIAN; CHILDHOOD LEUKEMIA; CHINESE; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOGENETICS; ETHNIC DIFFERENCE; ETHNICITY; FUSION GENE; GENE FREQUENCY; GENETIC SCREENING; GENETIC TRANSCRIPTION; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALAYSIA; MALE; POPULATION DIFFERENTIATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SINGAPORE;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALAYSIA; MALE; NEOPLASM PROTEINS; PROGNOSIS; RISK FACTORS; SINGAPORE;

EID: 33846406403     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318030ac4c     Document Type: Conference Paper

References (26)

1. Arico M, Valsecchi MG, Camitta B, et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med. 2000;342:998-1006.
2. Pui CH, Gaynon PS, Boyette JM, et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet. 2002;359:1909-1915.
3. Uckun FM, Pallisgaard N, Hokland P, et al. Expression of TELAML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia. Leukemia Lymphoma. 2001;42:41-56.
4. Rubnitz JE, Pui CH. Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia. Cancer Treatment Rev. 2003;29:31-44.
5. Pui CH, Sandlund JT, Pei D, et al. Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA. 2003;290:2001-2007.
6. Nakao M, Yokota S, Horiike S, et al. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia. Leukemia. 1996;10:1463-1470.
7. Liang DC, Shih LY, Yang CP, et al. Multiplex reverse transcription polymerase chain reaction assay for the detection of major fusion transcripts in Taiwanese children with B-lineage acute lymphoblastic leukemia. Med Pediatr Oncol. 2002;39:12-17.
8. Borkhardt A, Cazzaniga G, Viehmann S, et al. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in German and Italian multicenter therapy trials. Blood. 1997;90:571-577.
9. Hann I, Vora A, Harrison G, et al, UK Medical Research Council's Working Party on Childhood Leukaemia. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Br J Haematol. 2001;113:103-114.
10. Gill HK, Keoh TS, Dhaliwal JS, et al. TEL-AML1 frequency in multi-ethnic Malaysian pediatric acute lymphoblastic leukaemia. Cancer Genetics Cytogenetics. 2005;156:129-133.
11. Schrappe M, Reiter A, Ludwid WD, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. Blood. 2000;95:3310-3322.
12. Eden OB, Harrison G, Richards S, et al. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Leukemia. 2000;14:2307-2320.
13. Gaynon PS, Trigg ME, Heemera NA, et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia. 2000;14:2223-2233.
14. Raimondi SC. Current status of cytogenetic research in childhood acute lympho-blastic leukemia. Blood. 1993;81:2237-2251.
15. Pallisgaard N, Hokland P, Riishoj DC, et al. Multiplex reverse-transcription polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood. 1998;92:574-588.
16. Ariffin H, Chen SP, Wong HL, et al. Validation of a multiplex RT-PCR assay for screening significant oncogene fusion transcripts in children with acute lymphoblastic leukemia. Singapore Med J. 2003;44:517-520.
17. Gallagher R, Collins S, Trujillo J, et al. Characterization of the continuous, differentiating myeloid cell line (HL60) from a patient with acute promyelocytic leukemia. Blood. 1979;54:713-733.
18. Pui CH, Behm FG, Crist WM. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood. 1993;82:343-362.
19. Pieters R, denBoer ML, Durian M, et al. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia: implications for treatment of infants. Leukemia. 1998;12:1344-1348.
20. Pui CH, Sandlund JT, Pei D, et al. Improved outcome for children with acute lymphoblastic leukemia:results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood. 2004;104:2690-2696.
21. Silverman LB, Declerck L, Gelber RD, et al. Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995). Leukemia. 2000;14:2247-2256.
22. Beyermann B, Agthe AG, Adams HP, et al. Clinical features and outcome of children with first marrow relapse of acute lymphoblastic leukemia expressing BCR-ABL fusion transcripts. Blood. 1996;87:1532-1538.
23. Roy A, Cargill A, Love S, et al. Outcome after first relapse in childhood acute lymphoblastic leukaemia - lessons from the United Kingdom R2 trial. Br J Haematol. 2005;130:67-75.
24. Magalhaes IQ, Pombo-de-Oliviera MS, Bennett CA, et al. TEL-AML1 fusion gene frequency in paediatric acute lymphoblastic leukemia in Brazil. Br J Haematol. 2000;111:204-207.
25. Seeger K, Adams HP, Buchwald D, et al. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. Blood. 1998;91:1716-1722.
26. Shurtleff SA, Buijs A, Behm FG, et al. TEL/AML1 resulting from the cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia. 1995;9:1985-1989.